Reading the annual reports…
First time this company is opened: we are analysing its official reports. This can take up to a minute; after that the page loads instantly.
First time this company is opened: we are analysing its official reports. This can take up to a minute; after that the page loads instantly.
Belgium
In shortU C B is profitable, generates cash and holds more cash than debt, with revenue growing (+17.1% last year).
Financial health
Strong
Built from five areas over the last five annual reports. Tap an area to see the figures behind it.
| Operating marginShare of each sale left after running the business, before interest and tax. | 21.5% | 88/100 |
|---|---|---|
| Net marginShare of each sale left as profit after every cost, interest and tax. | 17.3% | 89/100 |
| Return on equityProfit earned on the money shareholders put in. Above 15% is strong. | 11.2% | 56/100 |
| Return on invested capitalProfit earned on all the capital used (equity and debt). Above 10% usually means a real competitive edge. | 12.1% | 81/100 |
Weight in the score: 25%
| Current ratioShort-term assets divided by short-term debts. Below 1 can mean tight cash. | 1.36× | 46/100 |
|---|---|---|
| Debt / equityDebt compared with the shareholders' stake. Above 2 is heavily indebted. | 0.00× | 100/100 |
| Net debt / EBITDAYears of operating profit needed to repay net debt. Below 2 is comfortable. | Net cash | 100/100 |
| Interest coverageHow many times operating profit covers interest. Below 2 is risky. | 6.62× | 49/100 |
| Altman Z''Bankruptcy-risk model. Above 2.6 safe, below 1.1 distress. | – | n/a |
Weight in the score: 25%
| Free cash flow marginCash left from each sale after investments. The money that can pay dividends or reduce debt. | 16.4% | 86/100 |
|---|---|---|
| Free cash flow / net incomeHow much accounting profit turns into real cash. Near 1 or above is healthy. | 0.95× | 81/100 |
| Years with positive free cash flow (last 5) | 4 of 4 | 100/100 |
Weight in the score: 20%
| Profitable years (last 5) | 4 of 4 | 100/100 |
|---|---|---|
| Years of revenue decline (last 5) | 1 of 3 | 44/100 |
| Revenue growth volatility | 13.3% | 62/100 |
| Operating margin volatility | 4.9% | 65/100 |
Weight in the score: 20%
| Revenue growth, 3-year average | 4.8% | 43/100 |
|---|---|---|
| EPS growth, 3-year average | 13.3% | 91/100 |
Weight in the score: 10%
Fiscal year 2024 · change vs prior year
European data comes from annual reports in ESEF format (since 2020). Industry and ticker are not provided by this source.
Annual figures as reported. Hover a bar or point for the exact value.
The last 4 fiscal years from the company's annual reports.
EUR millions; negative values in parentheses.
| Fiscal year | FY20 | FY21 | FY23 | FY24 |
|---|---|---|---|---|
| Revenue | 5,347 | 5,777 | 5,252 | 6,152 |
| Cost of revenue | 1,363 | 1,438 | 1,707 | 1,752 |
| Gross profit | 3,984 | 4,339 | 3,545 | 4,400 |
| Research & development | 1,569 | 1,629 | 1,630 | 1,781 |
| Operating income | 971 | 1,284 | 604 | 1,324 |
| Interest expense | 107 | 138 | 210 | 200 |
| Pre-tax income | 880 | 1,226 | 441 | 1,163 |
| Income tax | 119 | 170 | 98 | 98 |
| Net income | 732 | 1,058 | 343 | 1,065 |
| Diluted EPS | €3.77 | €5.45 | €1.76 | €5.48 |
Not computed: a required balance-sheet item is missing.
8/9
Nine yes-or-no tests on profitability, debt, liquidity and efficiency versus the prior year. 7 to 9 is strong, 0 to 3 is weak.
All figures: filings.xbrl.org (ESEF). Ratios and scores are computed by Scorvest (see how it works). Information only, not investment advice. How it works
Latest annual report: Dec 31, 2024 · Data updated Feb 27, 2025